|
| | 9,15-DIOXO-11ALPHA-HYDROXY-2,3,4,5-TETRANOR-PROSTAN-1,20-DIOIC-17,17,18,18,19,19-D6 ACID Basic information |
| Product Name: | 9,15-DIOXO-11ALPHA-HYDROXY-2,3,4,5-TETRANOR-PROSTAN-1,20-DIOIC-17,17,18,18,19,19-D6 ACID | | Synonyms: | 9,15-DIOXO-11ALPHA-HYDROXY-2,3,4,5-TETRANOR-PROSTAN-1,20-DIOIC-17,17,18,18,19,19-D6 ACID;TETRANOR-PGEM-D6;TETRANOR PROSTAGLANDIN E METABOLITE-D6;ZJAZCYLYLVCSNH-VFBFAAMGSA-N;tetranor-PGEM-d6 Exclusive | | CAS: | 1240398-16-6 | | MF: | C16H24O7 | | MW: | 328.36 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File |  |
| | 9,15-DIOXO-11ALPHA-HYDROXY-2,3,4,5-TETRANOR-PROSTAN-1,20-DIOIC-17,17,18,18,19,19-D6 ACID Chemical Properties |
| storage temp. | Store at -80°C | | solubility | DMF: 50 mg/ml,DMSO: 50 mg/ml,Ethanol: Not Stable,PBS (pH 7.2): 1 mg/ml |
| | 9,15-DIOXO-11ALPHA-HYDROXY-2,3,4,5-TETRANOR-PROSTAN-1,20-DIOIC-17,17,18,18,19,19-D6 ACID Usage And Synthesis |
| Uses | tetranor-PGEM-d6 contains six deuterium atoms at the 13, 13, 14, 14, 15, and 15 positions. It is intended for use as an internal standard for the quantification of tetranor PGEM by GC- or LC-mass spectrometry. Tetranor PGEM-d6 is the major urinary metabolite of PGE1 and PGE2. It is used as a urinary marker of PGE2 biosynthesis, and to monitor metabolism after infusion or injection of PGE1 as a pharmaceutical. [Cayman Chemical]
|
| | 9,15-DIOXO-11ALPHA-HYDROXY-2,3,4,5-TETRANOR-PROSTAN-1,20-DIOIC-17,17,18,18,19,19-D6 ACID Preparation Products And Raw materials |
|
